Delivery Order SPE2DB20D1004-SPE2DB24FF0A7

Award Date 12/7/23
Potential Completion Date 12/8/23
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies to the Defense Logistics Agency (DLA). The $1,795.56 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a completion date of January 12, 2024 and was made without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies to the Defense Logistics Agency (DLA). The $10,930.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of June 28, 2023 and was awarded on June 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, which is a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,293.60, was awarded on May 31, 2022, with a completion date of June 1, 2022. It is a firm fixed-price delivery order contract, and there is no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.63 firm fixed-price delivery order is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has an ultimate completion date of January 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,038.35, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies to the Defense Logistics Agency (DLA). The $1,043.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a ceiling value of $1,063.73 and a completion date of August 6, 2024. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,285.25 and a performance period through May 6, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies to the Defense Logistics Agency (DLA). The $1,182.88 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 30, 2023. The contract has a completion date of August 31, 2023 and is a firm-fixed price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,257.60, is a delivery order for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a firm fixed price and an ultimate completion date of April 15, 2025. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF0A7
    Delivery Order

This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies to the Defense Logistics Agency (DLA). The award, valued at $1,426.72, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of December 8, 2023. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally.

Generated 5/12/25, 10:17 AM